<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:bir="http://www.alacra.com/bir" xmlns:srp="http://www.alacra.com/srp" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>Northwest Biotherapeutics Inc RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Northwest Biotherapeutics Inc</description>
<link>http://www.alacrastore.com/company-snapshot/Northwest_Biotherapeutics_Inc-2501865</link>
<lastBuildDate>Monday, September 08, 2008 1:17:46 PM</lastBuildDate>
<alacra:xlsid>2501865</alacra:xlsid>
<alacra:company>Northwest Biotherapeutics Inc</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-27489356</link><guid isPermaLink="false">newstex/PRN-0005-27489356</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> SEATTLE, Aug. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN) today announced that Scott C. Stromatt, M.D., has been appointed Trubion's senior vice president and chief medical officer...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07005000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010005</newstex:cat><pubDate>8/18/2008 5:21:37 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18007000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Trubion Pharmaceuticals Announces Appointment of New Chief Medical Officer</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-27489356</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">CELL THERAPEUTICS INC</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">NORTHWEST BIOTHERAPEUTICS INC.</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">TRUBION PHARMACEUTICALS INC</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">Daniel J Burge</newstex:index_entry_person><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">Peter A Thompson</newstex:index_entry_person><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">SCOTT STROMATT</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">CTIC</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">NWBO</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">TRBN</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/bir/910668</link><guid isPermaLink="false">bir/910668</guid><bir:index_mode xmlns:bir="http://www.alacra.com/bir">norm</bir:index_mode><title>Northwest Biotherapeutics Inc.</title><bir:company xmlns:bir="http://www.alacra.com/bir">Northwest Biotherapeutics Inc.</bir:company><bir:cou xmlns:bir="http://www.alacra.com/bir">United States</bir:cou><bir:descr xmlns:bir="http://www.alacra.com/bir">Manufacturing: Manufactures vaccines to fight cancer cells.</bir:descr><bir:sic xmlns:bir="http://www.alacra.com/bir">2834</bir:sic><bir:naics xmlns:bir="http://www.alacra.com/bir">325412</bir:naics><bir:class xmlns:bir="http://www.alacra.com/bir">17</bir:class><bir:size xmlns:bir="http://www.alacra.com/bir">A</bir:size><bir:revenue xmlns:bir="http://www.alacra.com/bir">A</bir:revenue><bir:ticker xmlns:bir="http://www.alacra.com/bir">NWBO</bir:ticker><pubDate>5/21/2008 6:25:00 AM</pubDate><bir:docid xmlns:bir="http://www.alacra.com/bir">910668</bir:docid><category>Company Profiles &amp; Financials</category><alacra:ip>Gale Company Profiles</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/srp/1008121092</link><guid isPermaLink="false">srp/1008121092</guid><srp:index_mode xmlns:srp="http://www.alacra.com/srp">norm</srp:index_mode><description>...Address:##### ###th Avenue N.E., Suite ###, Bothell, Washington ##### Incorporated:DelawareWeb Site: www.nwbio.comSIC Classification: Pharmaceutical Preparations (####) Business Description: Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance immune system responses to effectively treat cancer. IPO Date: ##-##-####...

</description><srp:company xmlns:srp="http://www.alacra.com/srp">1008121092</srp:company><title>Northwest Biotherapeutics, Inc.</title><srp:cusip xmlns:srp="http://www.alacra.com/srp">66737P501</srp:cusip><srp:ticker xmlns:srp="http://www.alacra.com/srp">NWBO</srp:ticker><pubDate>10/6/2006 12:22:00 PM</pubDate><srp:docid xmlns:srp="http://www.alacra.com/srp">1008121092</srp:docid><category>Credit &amp; Investment Research</category><alacra:ip>SharkRepellent.net</alacra:ip></item></channel></rss>